Speaker 1: Bloomberg Audio Studios, podcasts, radio News, The.
Speaker 2: Stock Movers Report, your roundup of companies making moves in
Speaker 2: the stock market, harnessing the power of Bloomberg Data.
Speaker 1: Let's take a look at some starts on the move
Speaker 1: today in Europe. I'm Stephen Carroll with Caroline Hepker, and
Speaker 1: we're joined by Bloomberg reporter Chloe Madi Chloy. Good morning.
Speaker 1: Let's start with Novo Nordisk. This morning, their shares sharply higher.
Speaker 1: A dose of optimism.
Speaker 3: There was very strong demand for its weight loss pill
Speaker 3: in the first quarter, and so that means that the
Speaker 3: sales decline for this year is actually going to be
Speaker 3: a little bit less severe than was previously expected. So
Speaker 3: just to give some numbers on this, As of the
Speaker 3: week that ended on April seventeenth, more than two million
Speaker 3: prescriptions of that weight loss pill had been issued in
Speaker 3: the US. So it's really a major success for Novo,
Speaker 3: and this is very reassuring after a lot of setbacks
Speaker 3: over the past year or so for the company. It
Speaker 3: is worth noting that although this does come as a relief,
Speaker 3: it's a really good performance for the Wigo V pill.
Speaker 3: There are some challenges ahead and The big one is
Speaker 3: going to be that Eli Lilly has just launched its
Speaker 3: own obesity pill just last month, so there is a
Speaker 3: risk of losing market share to this new drug, and
Speaker 3: there's also questions as surrounding supply capacity when the pill
Speaker 3: from Nova actually launches in other countries beyond the US,
Speaker 3: and that is expected to happen in the second half,
Speaker 3: So there's some things to iron out, some hurdles ahead,
Speaker 3: but there's also some relief too, and we can see
Speaker 3: that reflected in those shares.
Speaker 4: Yeah, amazing, isn't the obesity pill amazing steps forward?
Speaker 3: Well?
Speaker 4: Drink makers are also struggling. Lots of industries are struggling
Speaker 4: with the repercussions of this really massive change because of
Speaker 4: drugs like a zempeg Diagio though seems to be bucking
Speaker 4: the trend. Why.
Speaker 3: Yeah, it's pretty good results from Diego. So the cells
Speaker 3: rose slightly in the quarter, so that was actually much
Speaker 3: better than what ALYSSA expected, which was expectations of a
Speaker 3: decline instead, and there was really strong growth in some geography,
Speaker 3: so Africa and Latin America did particularly well and that
Speaker 3: was enough to offset some significant weakness in the US.
Speaker 3: So this actually echoes what we heard from ab and
Speaker 3: BEV just yesterday with really strong beer demand in Colombia
Speaker 3: and Mexico and Peru and managing to offset the weakness
Speaker 3: in the US in China, and so it seems that
Speaker 3: we have got this trend of lower alcohol consumption which
Speaker 3: is driven by the uptake of weight loss drugs, as
Speaker 3: you mentioned, a general kind of health and wellness trend,
Speaker 3: and it was of course as well the cost of
Speaker 3: living pressures. But that limited alcohol consumption that's kind of
Speaker 3: limited now to some geography is not all it seems
Speaker 3: to be. And the performance in the US was still
Speaker 3: quite weak. So that is something that will need to
Speaker 3: be addressed by by management, and that is part of
Speaker 3: the CEO's plan. He said that some actions will be
Speaker 3: taken for that. He's also planning on fixing some other
Speaker 3: issues for the ADUR and things like poor service levels
Speaker 3: and things like too much focus on premium drinks as well.
Speaker 3: So now it'll focus more as well on some ready
Speaker 3: to drink, ready to drink portfolio like canned cocktails, which
Speaker 3: is something that abn BEV has been doing as well. Actually,
Speaker 3: so we are seeing things turning around slowly for the.
Speaker 1: Edge Okay, turning then to BMW, shares also higher in
Speaker 1: BMW this morning, operund six percent at the moment, and
Speaker 1: this is despite the international competition that the carmaker's facing.
Speaker 3: Yeah, at first glance, so there's actually some weakness for BMW.
Speaker 3: We're seeing some really intense competition, as you mentioned it
Speaker 3: in China. There's also the impact of tariffs and those
Speaker 3: have really hurt the margin. But then orders in Europe
Speaker 3: were actually stronger than expected of EVS in particular that
Speaker 3: was particularly strong, and a cash flow was solid to
Speaker 3: so all of that has allowed BMW to keep its
Speaker 3: guidance and so that's what investors have decided to focus
Speaker 3: on this morning, rather than the impact of that competition
Speaker 3: and of those tariffs, and Alis of called the results reasonable.
Speaker 3: So it's not groundbreaking, but given that all the challenges
Speaker 3: that are being faced by carmakers at the moment, the
Speaker 3: expectations are maybe not so high. But going forward, the
Speaker 3: risks really remain the same. China is still a big
Speaker 3: problem given how much market share BMW and those other
Speaker 3: companies are losing to local manufacturers, and then tariffs to
Speaker 3: there's still that current threat threat of twenty five percent
Speaker 3: tariffs unless the E ratifies the current trade deal. So
Speaker 3: still some issues but reassuring results so far.
Speaker 2: The Stock Movers report from Bloomberg Radio. Check back with
Speaker 2: us throughout the day for the latest roundup of companies
Speaker 2: making news on Wall Street and for the latest market
Speaker 2: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with
Speaker 2: the Bloomberg Business app.